UPDATE : Thursday, May 23, 2019
상단여백
‘Kolon’s extra data insufficient to explain Invossa mislabeling’ by Lee Hye-seon 2019-05-23 14:51
Regulator inspecting Kolon TissuGene in US this week by Lee Hye-seon 2019-05-20 14:22
Preventive use of statin lowers cardiovascular mortality by 44% in seniors by Lee Hye-seon 2019-05-15 11:54
YUHS to introduce ‘hospital medicine department' by Lee Hye-seon 2019-05-03 13:23
Yonsei Cancer Center to provide newest heavy ion therapy in 2022 by Lee Hye-seon 2019-05-02 15:43
라인
When will regulator visit Kolon TissueGene for inspection? by Lee Hye-seon 2019-05-02 14:09
Medical device output up 11.8% in 2018 by Lee Hye-seon 2019-04-30 11:25
[Reporter’s Notebook]MFDS incapable of reviewing new drugs? by Lee Hye-seon 2019-04-29 16:12
Diarrhea drug Smecta banned for children under 2 by Lee Hye-seon 2019-04-24 15:42
OECD guideline OKs Korean-developed eye irritation test by Lee Hye-seon 2019-04-22 15:33
라인
Kolon desperate to keep Invossa license amid suspicion of data fabrication by Lee Hye-seon 2019-04-18 11:16
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests by Lee Hye-seon 2019-04-11 16:00
Regulator to probe Kolon with all possible scenarios over Invossa debacle by Lee Hye-seon 2019-04-10 15:37
Peripheral neuropathy reported in liver cancer drug Stivarga by Lee Hye-seon 2019-04-09 15:25
Bodybuilders booked for smuggling anabolic steroids by Lee Hye-seon 2019-04-05 12:23
라인
Anticipation grows for bill to support advanced biopharmaceuticals by Lee Hye-seon 2019-04-04 15:25
Fate of Kolon Life Science hangs on Invossa-K test results by Lee Hye-seon 2019-04-03 18:14
Oriental doctor illegally mixes steroids in herbal treatment by Lee Hye-seon 2019-04-03 12:47
Argatroban raises bleeding risk in pregnant women by Lee Hye-seon 2019-04-01 15:29
Phase-3 trials of Huntington’s chorea treatment approved by Lee Hye-seon 2019-03-29 17:24
여백
여백
여백
Back to Top